News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
767,752 Results
Type
Article (69215)
Company Profile (291)
Press Release (698234)
Multimedia
Podcasts (174)
Webinars (27)
Section
Business (205533)
Career Advice (3084)
Deals (36234)
Drug Delivery (142)
Drug Development (85748)
Employer Resources (177)
FDA (17089)
Job Trends (15807)
News (354311)
Policy (34704)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (2948)
Academic (2)
Accelerated approval (40)
Adcomms (35)
Allergies (167)
Alliances (51814)
ALS (196)
Alzheimer's disease (1841)
Antibody-drug conjugate (ADC) (363)
Approvals (17308)
Artificial intelligence (635)
Autoimmune disease (214)
Automation (48)
Bankruptcy (332)
Best Places to Work (12205)
BIOSECURE Act (22)
Biosimilars (208)
Biotechnology (198)
Bladder cancer (176)
Brain cancer (69)
Breast cancer (694)
Cancer (5309)
Cardiovascular disease (475)
Career advice (2634)
Career pathing (43)
CAR-T (314)
CDC (67)
Celiac Disease (2)
Cell therapy (851)
Cervical cancer (42)
Clinical research (73041)
Collaboration (1954)
Company closure (6)
Compensation (1162)
Complete response letters (84)
COVID-19 (2949)
CRISPR (109)
C-suite (991)
Cystic fibrosis (153)
Data (6793)
Decentralized trials (2)
Denatured (61)
Depression (157)
Diabetes (542)
Diagnostics (7119)
Digital health (51)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (314)
Drug pricing (216)
Drug shortages (30)
Duchenne muscular dystrophy (268)
Earnings (83612)
Editorial (66)
Employer branding (21)
Employer resources (158)
Events (120781)
Executive appointments (1083)
FDA (20464)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (26)
Funding (1643)
Gene editing (232)
Generative AI (64)
Gene therapy (707)
GLP-1 (1108)
Government (5310)
Grass and pollen (8)
Guidances (387)
Healthcare (20147)
HIV (73)
Huntington's disease (57)
IgA nephropathy (92)
Immunology and inflammation (302)
Immuno-oncology (76)
Indications (140)
Infectious disease (3271)
Inflammatory bowel disease (220)
Inflation Reduction Act (16)
Influenza (132)
Intellectual property (270)
Interviews (585)
IPO (16891)
IRA (53)
Job creations (3988)
Job search strategy (2172)
JPM (68)
Kidney cancer (20)
Labor market (87)
Layoffs (639)
Leadership (42)
Legal (8233)
Liver cancer (99)
Longevity (24)
Lung cancer (708)
Lymphoma (396)
Machine learning (47)
Management (60)
Manufacturing (897)
MASH (187)
Medical device (14157)
Medtech (14228)
Mergers & acquisitions (20518)
Metabolic disorders (1442)
mRNA (198)
Multiple sclerosis (180)
NASH (22)
Neurodegenerative disease (397)
Neuropsychiatric disorders (99)
Neuroscience (3260)
Neurotech (1)
NextGen: Class of 2026 (7169)
Non-profit (5006)
Now hiring (40)
Obesity (682)
Opinion (342)
Ovarian cancer (176)
Pain (228)
Pancreatic cancer (250)
Parkinson's disease (332)
Partnered (36)
Patents (551)
Patient recruitment (570)
Peanut (65)
People (63683)
Pharmaceutical (68)
Pharmacy benefit managers (30)
Phase 1 (22645)
Phase 2 (31957)
Phase 3 (23959)
Pipeline (6383)
Policy (340)
Postmarket research (3016)
Preclinical (9907)
Press Release (70)
Prostate cancer (275)
Psychedelics (56)
Radiopharmaceuticals (313)
Rare diseases (1045)
Real estate (6485)
Recruiting (75)
Regulatory (26147)
Reports (49)
Research institute (2695)
Resumes & cover letters (472)
Rett syndrome (32)
RNA editing (20)
RSV (89)
Schizophrenia (161)
Series A (282)
Series B (204)
Service/supplier (9)
Sickle cell disease (110)
Special edition (24)
Spinal muscular atrophy (174)
Sponsored (46)
Startups (3751)
State (1)
Stomach cancer (18)
Supply chain (114)
Tariffs (90)
The Weekly (110)
Vaccines (1163)
Venture capital (100)
Weight loss (451)
Women's health (102)
Worklife (23)
Date
Today (157)
Last 7 days (723)
Last 30 days (3233)
Last 365 days (31479)
2026 (6382)
2025 (31699)
2024 (36286)
2023 (40793)
2022 (52014)
2021 (56895)
2020 (55823)
2019 (49368)
2018 (37453)
2017 (34322)
2016 (34343)
2015 (40071)
2014 (33759)
2013 (29883)
2012 (31388)
2011 (31240)
2010 (30150)
Location
Africa (1061)
Alabama (93)
Alaska (7)
Arizona (291)
Arkansas (15)
Asia (45069)
Australia (7909)
California (11922)
Canada (3426)
China (1229)
Colorado (506)
Connecticut (532)
Delaware (355)
Europe (104349)
Florida (1805)
Georgia (390)
Hawaii (3)
Idaho (66)
Illinois (976)
India (79)
Indiana (551)
Iowa (20)
Japan (465)
Kansas (126)
Kentucky (47)
Louisiana (36)
Maine (79)
Maryland (1476)
Massachusetts (8730)
Michigan (359)
Minnesota (644)
Mississippi (7)
Missouri (147)
Montana (36)
Nebraska (28)
Nevada (134)
New Hampshire (81)
New Jersey (3264)
New Mexico (33)
New York (3197)
North Carolina (1616)
North Dakota (9)
Northern California (5804)
Ohio (366)
Oklahoma (23)
Oregon (43)
Pennsylvania (2381)
Puerto Rico (23)
Rhode Island (47)
South America (1384)
South Carolina (63)
South Dakota (1)
Southern California (4687)
Tennessee (192)
Texas (1887)
United States (42924)
Utah (364)
Vermont (1)
Virginia (293)
Washington D.C. (80)
Washington State (974)
West Virginia (4)
Wisconsin (130)
Wyoming (2)
767,752 Results for "national institute of allergy and infectious diseases niaid".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Regulatory
Fired NIAID Director Claims Ouster Was Payback for Whistleblower Report
Jeanne Marrazzo, former director of the National Institutes of Allergy and Infectious Disease, was formally terminated Thursday after months on administrative leave, after filing a whistleblower report.
October 3, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV Development
February 6, 2025
·
12 min read
Drug Development
Traverse Biotech Awarded Phase I SBIR Grant by the National Institute of Allergy and Infectious Diseases for Development of Innate Immune Stimulator
Traverse Biotech, Inc. has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH.
May 1, 2024
·
1 min read
Genetown
BostonGene Announces Publication in Collaboration with National Cancer Institute and National Institute of Allergy and Infectious Diseases in Cancer Cell
BostonGene Announces Publication in Collaboration with National Cancer Institute and National Institute of Allergy and Infectious Diseases in Cancer Cell.
March 7, 2024
·
4 min read
BioCapital
ReAlta Life Sciences Announces New Research Collaboration with the National Institute of Allergy and Infectious Diseases to Evaluate RLS-0071 as a Medical Countermeasure for Acute Radiation Syndrome
ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”) today announces that the company will be utilizing the preclinical services program offered by the National Institute of Allergy and Infectious Diseases (NIAID) to evaluate RLS-0071 as a medical countermeasure for Acute Radiation Syndrome (ARS).
March 28, 2024
·
3 min read
Press Releases
The Lundquist Institute and its start-up company Vitalex Biosciences Announces Strategic Advancement of Second-Generation fungal Vaccine VXV-01 through Phase 1 Trials under $40 Million Competitive Contract from NIH/NIAID
December 16, 2025
·
4 min read
Press Releases
Tonix Pharmaceuticals Announces Participation in Endpoints Panel at the Long COVID Workshop and RECOVER TLC Workshop Convened by the Foundation for the National Institutes of Health (FNIH) and the National Institute of Allergy and Infectious Diseases (NIAID)
October 1, 2024
·
6 min read
Press Releases
Crestone Announces Positive Data from Phase 2 Clinical Trial of CRS3123 for C. difficile Infections Published in The Lancet Infectious Diseases
March 9, 2026
·
8 min read
Business
ATCC Announces Award from National Institute of Allergy and Infectious Diseases to Support Its Preclinical Services for Biopharmaceutical Product Development
ATCC , the world’s premier biological materials management and standards organization, today announced that it has been awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract 75N93023D00009 by the National Institute of Allergy and Infectious Diseases ( NIAID ), part of the National Institutes of Health (NIH).
November 7, 2023
·
2 min read
Venture capital
After Exiting 2seventy, Chip Baird Took a 180 to Food Allergy With Newly Launched Poplar
Poplar Therapeutics is seeking a “step change” in the treatment of food allergy and other atopic conditions, with $95 million raised to date, including a $45 million series A extension that closed Tuesday.
March 3, 2026
·
3 min read
·
Annalee Armstrong
1 of 76,776
Next
